M-tron Industries, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 12, 2026, covering the company's unaudited financial results for the third quarter and first nine months of fiscal 2026.
DeFi Development Corp. filed a Form 8-K with the SEC on November 12, 2026, reporting the issuance of a press release and its September 2026 Shareholder Letter and Business Update.
EZCORP Inc. Chief Legal Officer Ellen H. Bryant filed a Form 4 on November 12, 2026, disclosing the acquisition of 25,202 Restricted Stock Units on November 10, 2026, with a closing market reference value of $29.76 per share as of September 30, 2026.
CuriosityStream Inc. filed a Form 8-K on November 11, 2026, announcing a quarterly cash dividend and reporting third-quarter financial results for the period ended September 30, 2026.
Vertiv Holdings Co. filed an 8-K on November 12, 2026, disclosing the introduction of the Vertiv PowerNexus MV UPS, an outdoor-rated medium-voltage uninterruptible power system targeting colocation, neocloud, and hyperscale data center operators.
Allspring Global Dividend Opportunity Fund and three sibling closed-end funds announced on November 12, 2026, that their Boards of Trustees have authorized renewal of open-market share repurchase programs covering up to 5% of each fund's outstanding shares for the period January 1, 2027 through …
YS Management Company Limited and Yif Liu filed Amendment No. 3 to their Schedule 13D with the SEC on November 12, 2026, disclosing a reduced beneficial ownership percentage in AIFU Inc. following the company's issuance of new Class A ordinary shares on November 6, …
Canton Strategic Holdings, Inc. filed an 8-K press release on November 12, 2026, sharing comments on Maximum Extractable Value ("MEV") in onchain transactions and its potential impact on market structure for tokenized assets.
Sidus Space, Inc. (NASDAQ:SIDU) announced on November 12, 2026, that registered patent attorney and Widerman Malek, PL co-founder Mark R. Malek was appointed to its Board of Directors, effective November 11, 2026, becoming the third director added since October.
Silence Therapeutics plc filed a Current Report on Form 8-K on November 12, 2026, furnishing a press release with its financial and business results for the third quarter ended September 30, 2026, alongside an update on a definitive acquisition agreement with Merck KGaA, Darmstadt, …